88979-61-7

88979-61-7 structure
88979-61-7 structure
  • Name: Bafilomycin C1
  • Chemical Name: bafilomycin c1
  • CAS Number: 88979-61-7
  • Molecular Formula: C39H60O12
  • Molecular Weight: 720.88600
  • Catalog: Signaling Pathways Anti-infection Bacterial
  • Create Date: 2016-12-15 15:43:44
  • Modify Date: 2024-01-05 12:48:00
  • Bafilomycin C1 is a macrolide antibiotic isolated from Streptomyces sp. Bafilomycin C1 is a potent, specific and reversible inhibitor of vacuolar-type H+-ATPases (V-ATPases). Bafilomycin C1 inhibits growth of gram-positive bacteria and fungi[2]. Bafilomycin C1 induces cell apoptosis and can be used for the study of hepatocellular carcinoma (HCC)[2].

Name bafilomycin c1
Synonyms 2-Demethyl-2-methoxy-24-methylhygrolidin
Description Bafilomycin C1 is a macrolide antibiotic isolated from Streptomyces sp. Bafilomycin C1 is a potent, specific and reversible inhibitor of vacuolar-type H+-ATPases (V-ATPases). Bafilomycin C1 inhibits growth of gram-positive bacteria and fungi[2]. Bafilomycin C1 induces cell apoptosis and can be used for the study of hepatocellular carcinoma (HCC)[2].
Related Catalog
In Vitro Bafilomycin C1 (0.33-10 μM; 6 days) inhibits the growth and proliferation of SMMC7721 and HepG2 cells in a timeand dose-dependent manner[2]. Bafilomycin C1 (0.33-3.3 μM; 24 hours) decreases cyclin D3, cyclin E1, CDK2, CDK4, and CDK6 expression in both mRNA and protein expression in SMMC7721 cells[2]. Bafilomycin C1 (3.3-10 μM; 24 hours) causes morphological alterations and increases the population of apoptotic cells by Hoechst 33258 (HY-15558) staining compared to vehicle[2]. Cell Viability Assay[2] Cell Line: SMMC7721 cell and HepG2 cell Concentration: 0.33 μM, 1.1 μM, and 3.3 μM for SMMC7721 1.1 μM, 3.3 μM, and 10.0 μM for HepG2 Incubation Time: 6 days Result: Retarded the cell growth. Western Blot Analysis[2] Cell Line: SMMC7721 cells Concentration: 3.3 μM Incubation Time: 24 hours Result: Decreaed cyclin D3/E1,CDK2/4/6 protein expression and increased p21. Apoptosis Analysis[2] Cell Line: SMMC7721 and HepG2 cells Concentration: 3.3 μM; 10 μM Incubation Time: 24 hours Result: Induced apoptosis in SMMC7721 and HepG2 cells.
In Vivo Bafilomycin C1 (subcutaneous injection; 0.2 mg/kg; 20 days) retards the tumor growth without apparent adverse reactions or side effects in nude mice model[1]. Animal Model: BALB/c nude mice (weighing 18-20 g) subcutaneous injected by SMMC7721 cell suspension (5×106 cells/100 μL)[2] Dosage: 0.2 mg/kg Administration: Subcutaneous injection; 20 days Result: Suppressed tumor growth of SMMC7721 tumor xenografts.
References

[1]. E J Bowman, et al. Bafilomycins: A Class of Inhibitors of Membrane ATPases From Microorganisms, Animal Cells, and Plant Cells. Proc Natl Acad Sci U S A. 1988 Nov;85(21):7972-6.

[2]. Xiaoxiao Gao,et al.Bafilomycin C1 Induces G0/G1 Cell-Cycle Arrest and Mitochondrial-Mediated Apoptosis in Human Hepatocellular Cancer SMMC7721 Cells. J Antibiot (Tokyo). 2018 Sep;71(9):808-817.

Density 1.18 g/cm3
Boiling Point 844.4ºC at 760 mmHg
Molecular Formula C39H60O12
Molecular Weight 720.88600
Flash Point 248.9ºC
Exact Mass 720.40800
PSA 178.28000
LogP 4.88440
Index of Refraction 1.544
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.